Neurocrine Biosciences

PriceNeurocrine Biosciences

NBIX

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Historical stock price chart and annual return over the past years

13%

5 years

% Total

NBIX
2%

5 years

Annual Return

NBIX